The LRRK2 p.A419V (odds ratio (OR) 2.45), p.R1441C/G/H (OR 12.75), p.R1628P (OR 2.13), p.G2019S (OR 13.16), and p.G2385R (OR 2.27) mutations were associated with increased PD risk, whereas p.R1398H (OR 0.81) was associated with a decreased risk for PD [26] (Table 1). Here, LRRK2 is linked to Parkinson disease.